A new digital platform which aims to bring all parties involved in clinical trials together more coherently has been launched.
Veeva Digital Trials Platform, created by Spain-based health tech firm Veeva Systems, aims to “advance clinical trial execution”.
It provides a “complete and connected technology ecosystem that spans patients, research sites, and trial sponsors”.
Features include data management technology for sponsors and CROs and an application for sites to modernise their operations and run connected clinical trials with sponsors.
It also has an intuitive application that makes it easy for patients to participate in clinical research.
In terms of the patient consent process, sponsors can author and approve a consent form, which flows automatically to sites.
Sites can then modify the consent form, obtain relevant approval, and consent patients with a mobile application.
The patient status and consent form are immediately available as validated and reportable data for the sponsor.
Jim Reilly, vice president, Vault R&D at Veeva, said: “By bringing together the growing community of research sites using Veeva SiteVault Free with sponsors using Vault Clinical Suite, we aim to accelerate the move to digital trial execution.
“The Veeva Digital Trials Platform will make clinical trials easier and faster for patients, sites, and sponsors.”
LEO Pharma recently announced its partnership to adopt the complete Veeva Digital Trials Platform.
Jörg Möller, executive vice president and head of R&D at LEO Pharma, said: “We’ve been exploring ways to transform clinical trials, but COVID-19 sped up this process. By promptly responding to changing market dynamics, we kept our trials going without delay.
“Partnering with Veeva supports our 2030 strategy as it will help us to bring innovative treatments to patients faster while also supporting a more sustainable business.
“Veeva’s track record of product excellence makes it the ideal long-term partner to help us achieve this, enabling us to help patients faster and better.”
The platform is now available now for early adopters. See more here.